New Technology for Thyroid Nodule Radiofrequency Ablation: Adjustable Hot Tip.

New Technology for Thyroid Nodule Radiofrequency Ablation: Adjustable Hot Tip.

New Technology for Thyroid Nodule Radiofrequency Ablation: Adjustable Hot Tip.
New Technology for Thyroid Nodule Radiofrequency Ablation: Adjustable Hot Tip.
Dr.Guttler’s comments:
1. This is a great advance in the treatment of benign thyroid nodules.
2. It is not available in the USA at this time.
3. The peripheral nodule portions could be ablated with the small hot tip 5 mm to avoid injury to danger structures, and the central portion with the adjustable bigger hot tip 10 mm. The electrode gauge was #18.
4. 21 nodules were treated with a single electrode with adjustable hot tips.
5. Nodule volume decreased 68% and included improved symptoms and cosmetic problems.
6. The goal of 50% reduction was obtained in 91% at 12 months.
7. 3/21 had only minor complications.
Jung Hwan Baek MD, PhD reported this on ResearchGate
baek
Combining the 5 and 10 mm adjustable hot tip on the same #18 gauge electrode is a great invention as it can decrease the number of repeat procedures to get the outer area with the small hot tip with the first procedure.
                                                       Bravo Dr.Baek and team.
Objective:
The purpose of this study was to evaluate a novel radiofrequency ablation (RFA) application utilizing an adjustable electrode for treatment of benign thyroid nodules.
Materials and Methods:
From April 2011 to December 2018, 21 patients underwent RFA treatment on 21 thyroid nodules, utilizing an 18-gauge internally cooled electrode equipped with a size adjustable active tip. The peripheral nodule portions were ablated with the moving-shot technique and a shorter active tip, and the nodule centers were ablated with the fixed technique and a longer active tip. We assessed parameters including characteristics of the treated nodules, use of variable sized active tips, volume reduction rate, therapeutic success rate, and post-procedural complications. The therapeutic success rate was defined as a > 50% volume reduction of the initial nodule volume at the 6- or 12-month follow-up.
Results:
The treated thyroid nodules were large enough to cause symptoms (mean volume, 29.6 mL). Two types of active tips per session were used for all nodules. The mean volume reduction rate at the last follow-up was 68.3 ± 4.4% and our therapeutic success rate was 90.5%. Both symptoms and cosmetic scores decreased significantly. Minor complications in three patients were recorded during and after the procedure.
Conclusion:
This initial study demonstrated that an adjustable electrode for RFA of benign thyroid nodules effectively and safely resulted in volume reduction.
Objective:
The purpose of this study was to evaluate a novel radiofrequency ablation (RFA) application utilizing an adjustable electrode for treatment of benign thyroid nodules.
Materials and Methods:
From April 2011 to December 2018, 21 patients underwent RFA treatment on 21 thyroid nodules, utilizing an 18-gauge internally cooled electrode equipped with a size adjustable active tip. The peripheral nodule portions were ablated with the moving-shot technique and a shorter active tip, and the nodule centers were ablated with the fixed technique and a longer active tip. We assessed parameters including characteristics of the treated nodules, use of variable sized active tips, volume reduction rate, therapeutic success rate, and post-procedural complications. The therapeutic success rate was defined as a > 50% volume reduction of the initial nodule volume at the 6- or 12-month follow-up.
Results:
The treated thyroid nodules were large enough to cause symptoms (mean volume, 29.6 mL). Two types of active tips per session were used for all nodules. The mean volume reduction rate at the last follow-up was 68.3 ± 4.4% and our therapeutic success rate was 90.5%. Both symptoms and cosmetic scores decreased significantly. Minor complications in three patients were recorded during and after the procedure.
Conclusion:
This initial study demonstrated that an adjustable electrode for RFA of benign thyroid nodules effectively and safely resulted in volume reduction.
Objective:
The purpose of this study was to evaluate a novel radiofrequency ablation (RFA) application utilizing an adjustable electrode for treatment of benign thyroid nodules.
Materials and Methods:
From April 2011 to December 2018, 21 patients underwent RFA treatment on 21 thyroid nodules, utilizing an 18-gauge internally cooled electrode equipped with a size adjustable active tip. The peripheral nodule portions were ablated with the moving-shot technique and a shorter active tip, and the nodule centers were ablated with the fixed technique and a longer active tip. We assessed parameters including characteristics of the treated nodules, use of variable sized active tips, volume reduction rate, therapeutic success rate, and post-procedural complications. The therapeutic success rate was defined as a > 50% volume reduction of the initial nodule volume at the 6- or 12-month follow-up.
Results:
The treated thyroid nodules were large enough to cause symptoms (mean volume, 29.6 mL). Two types of active tips per session were used for all nodules. The mean volume reduction rate at the last follow-up was 68.3 ± 4.4% and our therapeutic success rate was 90.5%. Both symptoms and cosmetic scores decreased significantly. Minor complications in three patients were recorded during and after the procedure.
Conclusion:
This initial study demonstrated that an adjustable electrode for RFA of benign thyroid nodules effectively and safely resulted in volume reduction.
Call me for details of thyroid RF treatment for thyroid nodules and cancer.
13103938860
secure  email to [email protected]
Ask for Alicia.
Dr.G.
Endocrinologists call for details of 2 day private masters class in thyroid RF with observation of actual nodule treatment.
                               I use RF Medical system in my practice.
visual1_object
Add Your Comment

Contact Info
1328 16th Street, Santa Monica, CA 90404
Monday – Friday
9:00 AM to 5:00 PM
(310) 393-8860